Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (27)
  • Antibacterial
    (26)
  • Endogenous Metabolite
    (19)
  • Interleukin
    (18)
  • NF-κB
    (18)
  • Autophagy
    (16)
  • TNF
    (14)
  • Antibiotic
    (8)
  • Caspase
    (6)
  • Others
    (79)
TargetMol | Tags By Application
  • ELISA
    (8)
  • Functional assay
    (8)
  • FACS
    (5)
  • FCM
    (3)
Filter
Search Result
Results for "

immunomodulatory

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    220
    TargetMol | All_Pathways
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    19
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    14
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    1
    TargetMol | All_Dye_Reagents
  • PROTAC Products
    10
    TargetMol | PROTAC
  • Natural Products
    83
    TargetMol | Natural_Products
  • Recombinant Protein
    12
    TargetMol | Recombinant_Protein
  • Isotope Products
    7
    TargetMol | Isotope_Products
  • Disease Modeling
    5
    TargetMol | Disease_Modeling_Products
  • Cell Research
    6
    TargetMol | Cell_Research_Reagents
  • Reference Standards
    16
    TargetMol | Standard_Products
  • Oligonucleotides
    2
    TargetMol | All_Pathways
Proparacaine hydrochloride
Proxymetacaine Hydrochloride, Proparacaine HCl
T02225875-06-9
Proparacaine Hydrochloride is the hydrochloride salt form of proparacaine, a benzoic acid derivative with local anesthetic property. Proparacaine hydrochloride (Proparacaine HCl) stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby inhibiting sodium ion influx required for the initiation and conduction of impulses within the neuronal cell, and resulting in a loss of sensation.
  • $29
In Stock
Size
QTY
Inosine
NSC 20262, INO 495
T043758-63-9
Inosine (NSC-20262), an endogenous purine nucleoside produced by the catabolism of adenosine, is an agonist of adenosine receptors A1R and A2AR. Inosine has anti-inflammatory, immunomodulatory, antinociceptive and neuroprotective effects.
  • $29
In Stock
Size
QTY
TargetMol | Citations Cited
N,N'-Diacetyl-L-cystine
DiNAC, (Ac-Cys-OH)2
T162405545-17-5
N,N'-Diacetyl-L-cystine (DiNAC) is the disulphide dimer of N-acetylcysteine with immunomodulating properties. N,N'-diacetyl-L-cystine also has antiatherosclerotic effects in Watanabe-heritable hyperlipidemic rabbit (WHHL) rabbits. N,N'-diacetyl-L-cystine is also an effective and orally active modulator of contact sensitivity/delayed-type hypersensitivity reactions in rodents.
  • $33
In Stock
Size
QTY
Lenalidomide
CC-5013
T1642191732-72-6
Lenalidomide (CC-5013) is an immunomodulator with oral activity. Lenalidomide is a ligand for the ubiquitin E3 ligase cereblon (CRBN), which selectively ubiquitinates and degrades two lymphoid transcription factors, IKZF1 and IKZF3, via the CRBN-CRL4 ubiquitin ligase, and is commonly used in the synthesis of PROTAC products.
  • $36
In Stock
Size
QTY
TargetMol | Citations Cited
Lenalidomide hemihydrate
T22922847871-99-2
Lenalidomide hemihydrate is a derivative of Thalidomide, an orally active immunomodulator that acts as a molecular gel. It is a ligand for the ubiquitin E3 ligase cereblon, which selectively ubiquitinates and degrades two lymphoid transcription factors, IKZF1 and IKZF3, via the CRBN-CRL4 ubiquitin ligase.
  • $29
In Stock
Size
QTY
Vidofludimus
SC12267, 4sc-101
T2601717824-30-1
Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).
  • $54
In Stock
Size
QTY
TargetMol | Citations Cited
Avadomide
CC 122
T35491015474-32-4
Avadomide (CC 122) is an orally available pleiotropic pathway modulator with potential antineoplastic activity.
  • $40
In Stock
Size
QTY
TargetMol | Citations Cited
Telithromycin
RU66647, RU 66647, HMR3647, HMR 3647
T4543191114-48-4
Telithromycin is a semisynthetic 14-membered macrolide antibiotic and erythromycin derivative that binds to the 50S subunit of the 70S bacterial ribosome, inhibits bacterial protein synthesis, and exhibits antimicrobial activity against a wide range of gram-positive and gram-negative bacteria for the treatment of mild to moderate respiratory infections.
  • $77
In Stock
Size
QTY
Cilomilast
SB-207499, Ariflo
T6445153259-65-5
Cilomilast (SB-207499) is a potent PDE4 inhibitor with an IC50 of approximately 110 nM, demonstrating anti-inflammatory activity and minimal central nervous system effects. Phase 3.
  • $48
In Stock
Size
QTY
Ossirene
AS101
T6761106566-58-9
Ossirene (AS101), a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta converting enzyme.
  • $35
In Stock
Size
QTY
TargetMol | Citations Cited
physalin F
T871657423-71-9
Physalin F is a natural blocker of CaV2.3 (R-type) and CaV2.2 (N-type) voltage-gated calcium channels.It is a secosteroid with potent anti-inflammatory and immunomodulatory activities. Physalin F induces apoptosis of PBMC, decreasing the spontaneous proliferation and cytokine production caused by Human T-lymphotropic virus type 1 (HTLV-1) infection
  • $45
In Stock
Size
QTY
(E/Z)-IT-603
IT603
T8799292168-90-2
(E/Z)-IT-603 is a cell-permeable c-Rel inhibitor (IC50: 3μM) that directly and reversibly binds to c-Rel, altering its conformation and inhibiting its DNA binding and transcriptional activity.
  • $54
In Stock
Size
QTY
TC11
CLT-003, 1H-Isoindole-1,3(2H)-dione, 5-amino-2-[2,6-bis(1-methylethyl)phenyl]-TC11
T9083100823-03-8
TC11 (1H-Isoindole-1,3(2H)-dione, 5-amino-2-[2,6-bis(1-methylethyl)phenyl]-TC11) is a potent inhibitor of tumor cell proliferation and an inducer of apoptosis via activation of caspase-3, 8 and 9.
  • $33
In Stock
Size
QTY
Salvigenin
TMS174319103-54-9
Salvigenin is a potent hMAO-A inhibitor, has neuroprotective, antitumor and immunomodulatory effects.
  • $65
In Stock
Size
QTY
TargetMol | Citations Cited
glatiramer Acetate
TP2315147245-92-9
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relapsing remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS).
  • $39
In Stock
Size
QTY
Sulindac
Sulindac sulfoxide, MK-231, Clinoril, Arthrocine
T045938194-50-2
Sulindac (Sulindac sulfoxide) is a sulfinylindene derivative prodrug with potential antineoplastic activity. Converted in vivo to an active metabolite, sulindac, a nonsteroidal anti-inflammatory drug (NSAID), blocks cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE), an enzyme that inhibits the normal apoptosis signal pathway; this inhibition permits the apoptotic signal pathway to proceed unopposed, resulting in apoptotic cell death.
  • $40
In Stock
Size
QTY
p-Coumaric Acid Ethyl Ester
Ethyl trans-4-hydroxycinnamate, Ethyl (E)-p-hydroxycinnamate
T138087362-39-2
p-Coumaric Acid Ethyl Ester (Ethyl (E)-p-hydroxycinnamate) is the ethyl ester of p-Coumaric acid. p-Coumaric Acid is a common dietary polyphenol and also a potent immunosuppressive agent in treating autoimmune inflammatory diseases like rheumatoid arthritis.
  • $40
In Stock
Size
QTY
Thymopentin
TP5
T259869558-55-0
Synthetic pentapeptide corresponding to the amino acids 32-36 of thymopoietin and exhibiting the full biological activity of the natural hormone. Thymopentin (TP5) is an immunomodulator which has been studied for possible use in the treatment of rheumatoid arthritis, AIDS, and other primary immunodeficiencies.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
α-MSH
α-Melanocyte-Stimulating Hormone (MSH), amide, MSH, amide, CZEN-002
T7813581-05-5
α-MSH (MSH, amide) is amide stimulates melanocortin 1 receptor that results in the activation of adenylyl cyclase.
  • $53
In Stock
Size
QTY
TargetMol | Citations Cited
Baricitinib
LY3009104, INCB028050
T24851187594-09-7
Baricitinib (INCB028050) is a JAK1 and JAK2 inhibitor (IC50=5.9/5.7 nM) with selective and oral activity. Baricitinib has potential anti-inflammatory, immunomodulatory and anti-tumor activity.
  • $43
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Taurocholic acid
N-Choloyltaurine
TN225981-24-3
Taurocholic acid (N-Choloyltaurine) is a bile acid involved in fat emulsification, possessing notable biological and immunomodulatory activities. It can inhibit bile duct injury induced by hepatic artery ligation by upregulating VEGF-A expression and protect cholangiocytes from TNF-α-induced damage via a PI3K-mediated pathway, and is commonly used to induce pancreatitis models.
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
IPN60090
GLS1-IN-1
T114121853164-83-6In house
IPN60090 is a novel, potent, orally bioavailable, renal-type glutaminase (GLS1)-specific inhibitor with an IC50 value of 31 nM for GLS1. IPN60090 has potential anticancer and immunostimulant/immunomodulatory activity, selectively targets, binds, and inhibits human glutaminase, and can be used to study GLS1-mediated diseases.
  • $107
In Stock
Size
QTY
TargetMol | Citations Cited
(S)-Thalidomide
(S)-(-)-Thalidomide
T12644L841-67-8In house
(S)-Thalidomide ((S)-(-)-Thalidomide) is the S-isomer of Thalidomide with immunomodulatory, anti-inflammatory, anticancer, anti-angiogenic, and pro-apoptotic activities, used in studying leprosy erythema nodosum and myeloma.
  • $56
In Stock
Size
QTY
TOK-8801
T13180105963-46-0In house
TOK-8801 is a synthetic dihydroimidazole thiazole carboxamide with immunomodulatory activity that eliminates the stimulatory effects of antibody production by removing T cells.128-63-63-5
  • $176 TargetMol
In Stock
Size
QTY
TargetMol | Inhibitor Sale